Cosciens Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cosciens Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $-4.74 | $-3.24 | -46.3 % |
Dec 2023 | 2024-03-27 | $-4.64 | $-3.88 | -19.6 % |
Sep 2023 | 2023-11-09 | $-3.40 | $-2.44 | -39.3 % |
Jun 2023 | 2023-08-09 | $-2.08 | $-3.48 | 40.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $2.30M | $1.10M | 109.1 % |
Mar 2024 | 2024-05-14 | $4.00K | $1.10M | -99.6 % |
Sep 2023 | 2023-11-09 | $3.00K | $2.30M | -99.9 % |
Jun 2023 | 2023-08-09 | $2.25M | $1.14M | 97.0 % |
Cosciens Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3.
Cosciens Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was $-1.85, which missed the estimate of $0.00.
Cosciens Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.